Skip to main content

Advertisement

Log in

Risk factors associated with avascular fibrous membrane in patients with retinopathy of prematurity

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

We sought to assess the risk factors associated with avascular fibrous membrane development in patients with retinopathy of prematurity (ROP).

Methods

This retrospective, cross-sectional study included premature infants diagnosed with ROP. Gestational age, birth weight, stage and zone of the ROP, the presence of plus disease, and laser photocoagulation (LP) application were noted for each patient. Location, extension, development time, vanishing time of the avascular fibrous membrane, and associated complications were also noted. Patients who developed avascular fibrous membrane formed the membrane group (n = 38) and those who did not develop avascular fibrous membrane formed the control group (n = 208).

Results

Mean gestational age and birth weight did not differ between the groups (p = 0.897 and p = 0.343). ROP developed significantly earlier in the control group than in the membrane group (p < 0.001). The patients in the control group underwent LP treatment significantly earlier than did patients in the membrane group (p < 0.001). Regression analysis showed that higher postmenstrual age at the time of ROP diagnosis increased the risk of avascular fibrous membrane development by up to 1.6-fold (p = 0.002; 95% CI 1.2–2.3) and later LP treatment was associated with a 3.3-fold increased risk of avascular fibrous membrane development (p = 0.003; 95% CI 1.5–7.3).

Conclusions

Late-onset ROP and later LP treatment were found to be associated with an increased risk of avascular fibrous membrane development in patients with ROP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Ophthalmology AAoPSo (2013) Screening examination of premature infants for retinopathy of prematurity. Pediatrics 131:189–195

    Article  Google Scholar 

  2. Good WV, Early Treatment for Retinopathy of Prematurity Cooperative G (2004) Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 102:233–248 (discussion 248–250)

    PubMed  PubMed Central  Google Scholar 

  3. Sood BG, Madan A, Saha S, Schendel D, Thorsen P, Skogstrand K, Hougaard D, Shankaran S, Carlo W (2010) Perinatal systemic inflammatory response syndrome and retinopathy of prematurity. Pediatr Res 67:394–400

    Article  Google Scholar 

  4. Mutlu FM, Sarici SU (2013) Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options. Int J Ophthalmol 6:228–236

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Zhao S, Overbeek PA (2001) Elevated TGFbeta signaling inhibits ocular vascular development. Dev Biol 237:45–53

    Article  CAS  Google Scholar 

  6. Beranek M, Kankova K, Benes P, Izakovicova-Holla L, Znojil V, Hajek D, Vlkova E, Vacha J (2002) Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy. Am J Med Genet 109:278–283

    Article  Google Scholar 

  7. Group ETfRoPC (2006) Thef54098structural findings at age 2 years. Br J Ophthalmol 90:1378

    Article  Google Scholar 

  8. Terasaki H, Hirose T (2003) Late-onset retinal detachment associated with regressed retinopathy of prematurity. Jpn J Ophthalmol 47:492–497

    Article  Google Scholar 

  9. Lee BJ, Kim JH, Heo H, Yu YS (2012) Delayed onset atypical vitreoretinal traction band formation after an intravitreal injection of bevacizumab in stage 3 retinopathy of prematurity. Eye (Lond) 26:903–909 (quiz 910)

    Article  CAS  Google Scholar 

  10. Shah PK, Prabhu V, Karandikar SS, Ranjan R, Narendran V, Kalpana N (2016) Retinopathy of prematurity: Past, present and future. World J Clin Pediatr 5:35–46

    Article  Google Scholar 

  11. Lee AC, Maldonado RS, Sarin N, O’Connell RV, Wallace DK, Freedman SF, Cotten M, Toth CA (2011) Macular features from spectral domain optical coherence tomography as an adjunct to indirect ophthalmoscopy in retinopathy of prematurity. Retina 31:1470

    Article  Google Scholar 

  12. Zepeda EM, Shariff A, Gillette TB, Grant L, Ding L, Tarczy-Hornoch K, Cabrera MT (2018) Vitreous bands identified by handheld spectral-domain optical coherence tomography among premature infants. JAMA Ophthalmol 136:753–758

    Article  Google Scholar 

Download references

Acknowledgements

None.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Serdar Ozates.

Ethics declarations

Conflict of interest

The Authors declare that there is no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kabatas, E.U., Ozates, S. Risk factors associated with avascular fibrous membrane in patients with retinopathy of prematurity. Int Ophthalmol 40, 3005–3011 (2020). https://doi.org/10.1007/s10792-020-01484-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-020-01484-4

Keywords

Navigation